Conmed Corp (CNMD) Reports In-Line Q2 EPS; Lowers FY14 Outlook

Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $188.2 million versus the consensus estimate of $190.62 million.

Conmed Corp sees FY2014 EPS of $1.85-$1.95, versus prior guidance of $1.9-$2 and the consensus of $1.94. Conmed Corp sees FY2014 revenue of $735-745 million, versus prior guidance of $770-780 million and the consensus of $766.27 million.

For earnings history and earnings-related data on Conmed Corp (CNMD) click here.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Veralto Corporation (VLTO) Tops Q1 EPS by 6c, Offers Guidance
• New Oriental Education (EDU) Misses Q1 EPS by 12c ; Offers Guidance